Actual Medicinal Product (AMP) Revolade 50mg tablets (Novartis Pharmaceuticals UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Revolade 50mg tablets (Novartis Pharmaceuticals UK Ltd).

Generic
Eltrombopag
Formulation
Eltrombopag 50mg tablets
  • Eltrombopag
    • Eltrombopag 50mg tablets

      • Revolade 50mg tablets (Novartis Pharmaceuticals UK Ltd)